Search Results - Marc W. Retter

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Translational findings support regimen selection for first‐in‐human study of ubamatamab (MUC16 × CD3 bispecific antibody) in patients with recurrent ovarian cancer by Min Zhu, Priyanka Madia, Alison Crawford, Jurriaan Brouwer‐Visser, Pamela Krueger, Lauric Haber, Mary Peterman, Thomas S. Uldrick, Elizabeth Miller, John D. Davis, Marc W. Retter

    Published in Clinical and Translational Science (2024-12-01)
    Get full text
    Article


  2. 2

    A TMPRSS6-inhibiting mAb improves disease in a β-thalassemia mouse model and reduces iron in healthy humans by Heinrich E. Lob, Nikhil Singh, Kusha Mohammadi, Larisa Ivanova, Beth Crowell, Hyon J. Kim, Leah Kravets, Nanditha M. Das, Yonaton Ray, Jee Hae Kim, Sylvie Rottey, Emily Labriola-Tompkins, Hazem E. Hassan, Lorna Farrelly, Harvey F. Chin, Marilena Preda, Leigh Spencer Noakes, Kei Saotome, Matthew Franklin, Marc W. Retter, Elif Karayusuf, John J. Flanagan, William Olson, Kalyan C. Nannuru, Vincent Idone, Michael E. Burczynski, Olivier A. Harari, Lorah Perlee, Griet Van Lancker, Andrew J. Murphy, Aris N. Economides, Sarah J. Hatsell

    Published in JCI Insight (2025-07-01)
    Get full text
    Article


Search Tools: